BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33893674)

  • 1. Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes.
    Radbakhsh S; Barreto GE; Bland AR; Sahebkar A
    Biofactors; 2021 Jul; 47(4):570-586. PubMed ID: 33893674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy].
    Pupyshev AB; Korolenko TA; Tikhonova MA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 Sep; 66(5):515-540. PubMed ID: 30695399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.
    Chilumuri A; Odell M; Milton NG
    ACS Chem Neurosci; 2013 Nov; 4(11):1501-12. PubMed ID: 23968537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
    Moreno-Gonzalez I; Soto C
    Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
    Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
    Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The red-hot debate about transmissible Alzheimer's.
    Abbott A
    Nature; 2016 Mar; 531(7594):294-7. PubMed ID: 26983522
    [No Abstract]   [Full Text] [Related]  

  • 9. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
    Furkan M; Khan RH
    Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
    Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
    Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
    Esteras N; Abramov AY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease.
    Li D; Liu C
    Nat Chem Biol; 2021 Mar; 17(3):237-245. PubMed ID: 33432239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wildlife sequences of islet amyloid polypeptide (IAPP) identify critical species variants for fibrillization.
    Fortin JS; Benoit-Biancamano MO
    Amyloid; 2015; 22(3):194-202. PubMed ID: 26300107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK: Potential Therapeutic Target for Alzheimer's Disease.
    Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R
    Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical studies of protein misfolding and aggregation in
    Sinnige T; Stroobants K; Dobson CM; Vendruscolo M
    Q Rev Biophys; 2020 Jun; 49():e22. PubMed ID: 32493529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.